{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:03:22Z","timestamp":1789614202358,"version":"build-2803163510"},"reference-count":11,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"unspecified","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS110779"],"award-info":[{"award-number":["R01 NS110779"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01NS059041"],"award-info":[{"award-number":["U01NS059041"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01NS061861"],"award-info":[{"award-number":["U01NS061861"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01NS062091 U01NS056975"],"award-info":[{"award-number":["U01NS062091 U01NS056975"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2023,7,11]]},"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Acute blood pressure (BP) reduction is standard of care after acute intracerebral haemorrhage (ICH). More acute BP reduction is associated with acute kidney injury (AKI). It is not known if the choice of antihypertensive medications affects the risk of AKI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We analysed data from the ATACH-II clinical trial. AKI was defined by the Kidney Disease: Improving Global Outcomes criteria. We analysed antihypertensive medication from two sources. The first was a case report form that specified the use of labetalol, diltiazem, urapidil or other. We tested the hypothesis that the secondary medication was associated with AKI with \u03c7<jats:sup>2<\/jats:sup> test. Second, we tested the hypotheses the dosage of diltiazem was associated with AKI using Mann-Whitney U test.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>AKI occurred in 109 of 1000 patients (10.9%). A higher proportion of patients with AKI received diltiazem after nicardipine (12 (29%) vs 21 (12%), p=0.03). The 95%ile (90%\u201399%\u2009ile) of administered diltiazem was 18 (0\u2013130)\u2009mg in patients with AKI vs 0 (0\u201330)\u2009mg in patients without AKI (p=0.002). There was no apparent confounding by indication for diltiazem use.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The use of diltiazem, and more diltiazem, was associated with AKI in patients with acute ICH.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjno-2023-000458","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T13:00:11Z","timestamp":1690549211000},"page":"e000458","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Blood pressure medication and acute kidney injury after intracerebral haemorrhage: an analysis of the ATACH-II trial"],"prefix":"10.1136","volume":"5","clinical-trial-number":[{"clinical-trial-number":"nct01176565","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1065-5417","authenticated-orcid":false,"given":"Andrew M","family":"Naidech","sequence":"first","affiliation":[{"name":"Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyin","family":"Wang","sequence":"additional","affiliation":[{"name":"Health Services Integrated Program, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Hutch","sequence":"additional","affiliation":[{"name":"Health Services Integrated Program, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianne","family":"Murphy","sequence":"additional","affiliation":[{"name":"Health Services Integrated Program, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Paparello","sequence":"additional","affiliation":[{"name":"Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Bath","sequence":"additional","affiliation":[{"name":"Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, Illinois, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Illinois, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,7,28]]},"reference":[{"key":"2025072812051832000_5.2.e000458.1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.013326"},{"key":"2025072812051832000_5.2.e000458.2","first-page":"1274","article-title":"Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage","volume":"369","author":"Anderson","year":"2013","journal-title":"N Engl J Med"},{"key":"2025072812051832000_5.2.e000458.3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.25793","article-title":"Ultra-early blood pressure reduction attenuates hematoma growth and improves outcome in intracerebral hemorrhage","volume":"88","author":"Li","year":"2020","journal-title":"Ann Neurol"},{"key":"2025072812051832000_5.2.e000458.4","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1603460","article-title":"Intensive blood-pressure lowering in cerebral hemorrhage","volume":"375","author":"Qureshi","year":"2016","journal-title":"N Engl J Med"},{"key":"2025072812051832000_5.2.e000458.5","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000407"},{"key":"2025072812051832000_5.2.e000458.6","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.030272"},{"key":"2025072812051832000_5.2.e000458.7","unstructured":"Qureshi A . Data from: antihypertensive treatment of acute cerebral hemorrhage-II. n.d. Available: https:\/\/www.ninds.nih.gov\/current-research\/research-funded-ninds\/clinical-research\/archived-clinical-research-datasets"},{"key":"2025072812051832000_5.2.e000458.8","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.kint.2021.06.028","article-title":"Harmonizingacute and chronic kidney disease definition and classification: report of aKidney disease: improving global outcomes (KDIGO) consensus conference","volume":"100","author":"Lameire","year":"2021","journal-title":"Kidney Int"},{"key":"2025072812051832000_5.2.e000458.9","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1007\/s00134-018-5386-3","article-title":"Performance of doppler-based resistive index and semi-quantitative renal perfusion in predicting persistent AKI: results of a prospective multicenter study","volume":"44","author":"Darmon","year":"2018","journal-title":"Intensive Care Med"},{"key":"2025072812051832000_5.2.e000458.10","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.016771"},{"key":"2025072812051832000_5.2.e000458.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30194-1"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2023-000458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T19:05:28Z","timestamp":1753729528000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2023-000458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":11,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,7,28]]},"published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1136\/bmjno-2023-000458"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2023-000458","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]}}}